Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

Similar documents
Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017

Electronic Cigarettes: What we know so far

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

The Latest on Vaping Among U.S. Teens

Use of e-cigarettes (vapourisers) among adults in Great Britain

E-Cigarettes: Current Perspective

ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this

Public Health England s Independent Expert E-Cigarettes Evidence Review

E.cigarettes. An alternative to a uniquely deadly product that kills one in two of its regular users? Paul Lambert Public Health, Leeds City Council

The importance of offering adult smokers a portfolio of potentially less harmful products

Assessment of the Tobacco Heating System (THS) 2.2, A Candidate Modified Risk Tobacco Product: From Concept to Early Clinical Data

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS

Use of electronic cigarettes (vapourisers) among adults in Great Britain

E-cigarettes: Evidence, perceptions and misconceptions. Martin Dockrell, Tobacco Control Programme Lead

Heat-not-Burn Products: Scientific Assessment of Risk Reduction

Lung Cancer Epidemiology & Prevention. A/Prof Fraser Brims

Analysis and Evaluation of a Cross-Sectional Study IEA World Congress of Epidemiology 20 th August Saitama, Japan

Electronic Cigarettes and the Medical Society

REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD

Electronic Nicotine Delivery Systems

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery

Coach on Call. Thank you for your interest in E-Cigarettes: Your Questions Answered. I hope you find this tip sheet helpful.

Is Vaping a Valid Strategy for Smoking Cessation? Myths and Facts Jaspreet S. Brar. MD, PhD Community Care Behavioral Health Organization

Text 1: E-Cigarettes, the solution or another risk factor?

Dual Use: If Electronic Cigarettes are so good, why are there so few exclusive users?. Jonathan Foulds, PhD

RE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health

Welcome Superheros! YOUR. Winter Awareness Workshop 2017 BE A HERO IN COMMUNITY!

The concept that not all tobacco and nicotine products

E-Cigarettes and Vapes

Prevent disease Protect from injury Promote healthy lifestyles

Stop the Vape. Maria Hines RN, MSN. Denise Kneubuhler RN, MSN

Do Electronic Cigarettes Have Any Potential for Smoking Cessation? Professor Chris Bullen MBChB, MPH, PhD SRNT Webinar December 8th 2016

E-cigarettes and personal vapourisers: current research and policy

The State of Smoking 2018 Global Survey Findings and Insights. Monday, March 19, 2018

Use of electronic cigarettes among children in Great Britain

Vape to break the smoking habit

JUUL and Other Emerging Tobacco Products. Emily McClelland, M.S. December 6, 2018

HHS Public Access Author manuscript J Patient Cent Res Rev. Author manuscript; available in PMC 2016 February 04.

Smoke and mirrors: is vaping useful for smokers who cannot quit?

Electronic Cigarettes: What They Are, How They re Marketed, & How We Can Protect Our Youth

Safety/risk assessment of electronic cigarettes

Nicotine Reduction: Harm Reduction not Prohibition

Sweet Cheap Easy to Get. Tobacco industry tactics. Introduction. Tobacco Industry Tactics 5/1/2018

SAFETY E-CIGS: CLINICAL STUDIES

A proposed bridging approach for the assessment of novel tobacco products

Should FDA try to move smokers to e-cigarettes or other less harmful tobacco-nicotine products and, if so, how?

Health Effects of Electronic Nicotine Delivery Systems: A Systematic Review

E-CIGARETTES CANCER INSIGHT WHAT YOU NEED TO KNOW ABOUT. FOR GPs. INSIDE: A3 poster to display in your practice. October Created by Freepik

Air Quality assessment during indoor use of the Tobacco Heating System 2.2

E-cigarettes surpass tobacco cigarettes among teens

West Milford Township Public Schools. Substance Abuse Policy and Regulation Review. and Vape Education for Parents. April 26, 2018

Electronic Cigarettes

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures

Cardiovascular effects of nicotine vs. cigarette smoke

Tobacco Heating System 2.2, A Candidate Modified Risk Tobacco Product: Cardiovascular Disease Risk Assessment

The State of Smoking 2018 Global Survey Findings and Insights. Monday, March 19, 2018

Melodie Tilson, Director of Policy

Exploring five common claims about e-cigarette use. Lion Shahab, PhD University College

TOBACCO PRODUCT OR MEDICAL PRODUCT?

E-CIGARETTES CANCER INSIGHT WHAT YOU NEED TO KNOW ABOUT FOR PRACTICE NURSES. INSIDE: A3 poster to display in your practice.

Helping Smokers to Quit in General Practice

Experimental trial on the effectiveness of IQOS compared to e-cigarettes and regular tobacco cigarettes

Non-Industry Voices on Tobacco Harm Reduction and Vaping Products

Harmful and potentially harmful constituents in e-cigarettes

Introduction. Principles

Clearing The Air about: Gretchen Hagenbuch, M.Ed. SAP Coordinator Philadelphia Region

Actual Use Study of the Potential Reduced-Risk Product (RRP): Tobacco Heating System (THS)

Heated Tobacco Technology: Science, Behavior and Avoiding Unintended Consequences

E-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences

Kevin Walton, Ph.D. Chief, Clinical Research Grants Branch Division of Therapeutics and Medical Consequences NIDA. No disclosures

Learning Objectives 4/3/2018 UP IN SMOKE: NAVIGATING THE CHANGING LANDSCAPE OF SMOKING CESSATION BACKGROUND

E-cigarettes. Threat or opportunity?

E-Cigarette Update: Secondhand Vapour

Effectiveness of electronic cigarettes for smoking substitution

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products

Electronic Nicotine and Non Nicotine Delivery Systems (ENDS)

Global E-Cigarette Market- Industry Analysis & Outlook ( )

TREATMENT OF TOBACCO USE DISORDERS E-CIGS & APPS

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

Horace Greeley High School Parent Presentation Vaping, E-cigs and the Health of Our Youth. Richard Stumacher, MD, FCCP January 18, 2018

Tobacco Cessation, E- Cigarettes and Hookahs

My story parallels many of my own customers. I smoked for nearly 20 years, beginning in college, a combination of factors contributing to my

Electronic cigarettes: A new era for tobacco harm reduction Adapted for SW Specialist Nurses for Children in Care meeting 17 January 2017

UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY

CURRENT ISSUES IN TOBACCO CESSATION FOR THE PRACTICING PHYSICIAN

Preventing Youth Electronic Cigarette Use: Partnering with Schools

Texas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes

Trends in electronic cigarette use in England

CREATING A TOBACCO-FREE GENERATION A Tobacco Control Strategy for Scotland. Dr Catherine Calderwood Chief Medical Officer For Scotland

FORMs of TOBACCO. 2 nd of 3 Prep for Session 1

RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS

National Conference of State Legislatures Legislative Summit: Clearing the Air About E-Cigarettes

Policy Options for the Regulation of Electronic Cigarettes

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes

The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need

ΕΝΑΛΛΑΚΤΙΚΕΣ ΜΟΡΦΕΣ ΚΑΠΝΙΣΜΑΤΟΣ

The New Zealand experience with electronic cigarettes

Transcription:

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

2

Agenda Smoking is still a problem Stopping is hard Electronic cigarettes Reduced Risk tobacco products

Males >15yr smoking prevalence (WHO) 4

Percentage of smokers by age and sex, 2014 Source: Opinions and Lifestyle Survey - Office for National Statistics 5

Smoking prevalence in Ireland

Smoker/non smoker mortality ratios On average about 170% mortality compared to non smokers 7

John Schoonbee Smoking, e-cig and RRPs IMS 2017 8

How does quitting (/switching) improve health? Stopping gains 4-10 yrs of life (age dependent) N Engl J Med 2013;368:341-50 9

How easy is it to quit? 2/3 want to, ~5% manage Options include cold turkey gum, patches medication (switching) http://www.dailymail.co.uk/news/article-2060414/want-quit-smoking-studyfinds-6-cent-try-succeed---graduates-likely-kick-habit.html https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2376894/pdf/09 80317.pdf

Electronic Cigarettes - Introduction electronic nicotine-delivery system (ENDS) Electronic cigarettes (e-cigarettes) : nicotine, flavour and other chemicals. They turn chemicals, including nicotine, into an aerosol (using an atomizer) that is inhaled by the user no smoke, no tobacco - creates a vapour hence the term vaping 11

Current adult e-cigarette smokers (2010-2015) % of all adult GB smokers ASH Fact Sheet on the use of electronic cigarettes among adults in Great Britain May 2015 12

E-cigarettes - are they harmful? the constituents of cigarette smoke that harm health including carcinogens are either absent in e-cigarette vapour or, if present, they are mostly at levels much below 5% of smoking doses (mostly below 1% and far below safety limits for occupational exposure) BMJ 2015;351:h4634 13

E-cigarettes - what about the aldehydes? Recent reports raised a possibility that under certain conditions, EC may release high levels of aldehydes (released in tobacco smoke and contribute to its toxicity) Aldehydes are also released with thermal degradation of propylene glycol and glycerol in e-liquids. Previous studies detected the presence of aldehydes, especially formaldehyde, in the vapour from some EC, but at levels much lower than in cigarette smoke. Across brands, EC released 1/50th of the level of formaldehyde released by cigarettes. The highest level detected was six times lower than the level in cigarette smoke. Normal vaping generated negligible aldehyde levels. (McRobbie, H., et al., Effects of the use of electronic cigarettes with and without concurrent smoking on acrolein delivery. 2014) Farsalinos, K. E Cig aerosol contains 6 x LESS formaldehyde than tobacco cigarette smoke. 2014, Farsalinos, C., E-cigarette aerosols generates high levels of formaldehyde only in 'dry puff' conditions. Addiction 14

E-cigs haven t been shown to be effective There haven t been any scientific studies that prove e-cigs actually help people to quit smoking. There is also concern that using e-cigs may lead kids to start smoking regular cigarettes. The bottom line is that we just don t know enough about e-cigs, so we don t recommend that you use them. smokefree.gov John Schoonbee Smoking, e-cig and RRPs IMS 2017 1 15 5

Youth effect CONCLUSIONS: Most US youth view e-cigarettes as less harmful and addictive than cigarettes. Far fewer think similarly about cigars and smokeless tobacco. Increases in e-cigarettes perceived safety mirrors rapid increases observed in their use. Perceived safety correlates with use of each tobacco product. Pediatrics Nov 2016, 138 (5) e20154306

Pediatrics. 2016;138(2):e20153983 Youth effect

https://commons.wikimedia.org/wiki/file:naomi_214.2_(12883884613).jpg#/media /File:Naomi_214.2_(12883884613).jpg Switching from smoking to vaping avoids most of the risks of smoking and smokers should be encouraged to do so. E-cigarettes currently are much more popular than other treatments and hence have much wider reach and potential for a major public health impact. Public Health England s position on e-cigarettes BMJ 2015;351:h4863 18 John Schoonbee Smoking, e-cig and RRPs IMS 2017 1 8

E-cigarette users and quitting smoking Caponnetto P, et al. (2013) EffiCiency and Safety of an electronic cigarette (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study. PLoS ONE 8(6): e66317. doi:10.1371 19

E-cigarette users and quitting smoking Respondents were categorized as intensive users (used e-cigarettes daily for at least 1 month), intermittent users (used regularly, but not daily for more than 1 month), and non-users/triers (used e-cigarettes at most once or twice). Logistic regression controlling for demographics and tobacco dependence indicated that intensive users of e-cigarettes were 6 times more likely than non-users/triers to report that they quit smoking (OR: 6.07, 95% CI = 1.11, 33.2). Nicotine Tob Res. 2015 Feb;17(2):127-33 20

Reduced Risk Tobacco Products 21

Background Philip Morris International CEO has stated : no more combustible cigarettes by 2050 PMI has invested 3bn USD in developing a new reduced risk product (RRP) no combustion, only heating of tobacco to 300 C heat not burn The data shows risk reduction of >90% (compared to traditional cigarettes) They have launched in multiple markets Japan, Europe and UK - in Japan alone they have ~15% of the smokers on RRPs Single digit % of smokers manage to give up, PMI have managed over 70% conversion in Japan (first market) This is the first of 4 different platforms they are developing, all reduced risk products. The second is in live city testing. 22

Switching vs. Cessation 23

Reduction in exposure Reduction in metabolites, carcinogens equivalent to abstinence when smokers switch to RRP CC combustible cig THS RRP SA - abstinence 2 4

FDA approval How successful will they be? reduced exposure reduced risk reduced TRI s

What we have think about How to test if someone still inhales nicotine? How sustainable is the switch? How absolute is the switch? Do we really know long term outcomes? Nicotine =?lifelong addiction How much lower is the risk?? 26

Disclaimer The views expressed in this presentation are those of the presenter(s) and not necessarily of the Society of Actuaries in Ireland

Legal notice 2018 Swiss Re. All rights reserved. You are not permitted to create any modifications or derivative works of this presentation or to use it for commercial or other public purposes without the prior written permission of Swiss Re. The information and opinions contained in the presentation are provided as at the date of the presentation and are subject to change without notice. Although the information used was taken from reliable sources, Swiss Re does not accept any responsibility for the accuracy or comprehensiveness of the details given. All liability for the accuracy and completeness thereof or for any damage or loss resulting from the use of the information contained in this presentation is expressly excluded. Under no circumstances shall Swiss Re or its Group companies be liable for any financial or consequential loss relating to this presentation. 28